NCT02660827View on ClinicalTrials.gov

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

April 18, 2016

Primary Completion Date

November 28, 2018

Study Completion Date

February 1, 2021

Conditions
Type 1 Diabetes
Interventions
DEVICE

Insulin Pump

Closed Loop Algorithm

Trial Locations (11)

30318

Atlanta Diabetes Associates, Atlanta

32207

Nemours Children's Clinic, Jacksonville

33620

University of South Florida - USF Health, Tampa

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

80045

Barbara Davis Center, Aurora

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

90505

SoCal Diabetes, Torrance

92025

AMCR Institute, Escondido

94305

Stanford Hospital and Clinics, Palo Alto

Unknown

Sheba Medical Center, Tel Aviv

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT02660827 - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter